MRK's decision to stop the late-stage HYPERION study on PAH drug Winrevair ahead of time comes after evaluating the drug's ...

Morgan Stanley analyst Terence Flynn has maintained their neutral stance on MRK stock, giving a Hold rating yesterday.Invest with Confidence: ...

US pharma giant Merck & Co today revealed an early stop to the Phase III HYPERION study evaluating Winrevair (sotatercept-csrk) versus placebo (both in combination with background therapy) in recently ...

The CoinDesk 20 Index provides a benchmark for institutional investors beyond Bitcoin and Ethereum exchange-traded funds. It has gained adoption among hedge funds and asset managers since its ...

Institution-focused digital asset technology and trading firm BlockFills is collaborating with CoinDesk Indices to launch ...

Merck (MRK) announced the Phase 3 HYPERION study evaluating WINREVAIR versus placebo in recently diagnosed adults with pulmonary arterial ...

Merck , known as MSD outside of the United States and Canada, announced today the Phase 3 HYPERION study evaluating WINREVAIR (sotatercept-csrk) versus placebo (both in combination with background ...

Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final ...

Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...

PayPal Pay in 4 is an interest-free buy now, pay later service that lets you spread out the cost of an online purchase over ...

IperionX Limited, a company specializing in miscellaneous metal ores, today reported its quarterly results in a filing with ...

Hyperion's investment process uses rigorous and in-depth quantitative ... you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of ...